Who owns Genes?

Key details on Genes (Ticker: GCO)

Who owns Genes?

Is GCO a good stock to own? Find out who bought Genes, who sold Genes (GCO) stock, and who holds a large position in Genes.

Fund Name Number of Shares Share Valuation As Of
FMR 3.68M $269.00M Dec. 31, 2013
Damian Sousa 3.19M $233.31M Dec. 31, 2013
Royce & Associates 1.59M $115.87M Dec. 31, 2013
Vanguard 1.49M $108.68M Dec. 31, 2013
BlackRock Fund Advisors 1.32M $96.36M Dec. 31, 2013
Charles Schwab Bank 818666 $13.62M March 31, 2013
STATE STREET CORPORATION 684972 $50.04M Dec. 31, 2013
LOMBARDIA CAPITAL PARTNERS 672786 $49.15M Dec. 31, 2013
Cambiar Investors 635740 $46.45M Dec. 31, 2013
CHILTON INVESTMENT 632377 $41.47M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 629396 $45.98M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 606713 $44.33M Dec. 31, 2013
Vinik Asset Management 603889 $36.32M June 30, 2012
Pembroke Management 578500 $42.27M Dec. 31, 2013
Buckingham Capital Management 561826 $37.49M Sept. 30, 2012
Columbus Circle Investors 537205 $35.85M Sept. 30, 2012
Ranger Investment Management 521640 $34.81M Sept. 30, 2012
Franklin Resources 508700 $37.17M Dec. 31, 2013
OppenheimerFunds 501566 $27.59M Dec. 31, 2012
LORD, ABBETT & CO 501000 $36.60M Dec. 31, 2013
Rainier Investment Management 500830 $33.42M Sept. 30, 2012
Integrity Asset Management 458139 $17.18M Dec. 31, 2010
Inves 452496 $30.20M Sept. 30, 2012
FRIESS ASSOCIATES 451500 $32.35M March 31, 2012
GOLDMAN SACHS 439747 $29.34M Sept. 30, 2012
Macquarie 431725 $31.54M Dec. 31, 2013
NORTHERN TRUST 395087 $28.87M Dec. 31, 2013
Heather K. Mellem, Esq. 393337 $21.63M Dec. 31, 2012
Luther King Capital Management Corporation 390360 $21.47M Dec. 31, 2012
BlackRock Advisors 360685 $26.35M Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 348449 $22.85M Sept. 30, 2013
Scopus Asset Management 335100 $20.16M June 30, 2012
Ameriprise Financial 322642 $19.41M June 30, 2012
American Century Companies 319756 $17.59M Dec. 31, 2012
Fisher Investments 318669 $21.35M June 30, 2013
Loomis, Sayles and 308052 $22.51M Dec. 31, 2013

Who sold Genes?

Fund Name Date Sold Number of Shares Sold Share Valuation
Mason Street Advisors Sept. 30, 2011 390454 $20.12M
Munder Capital Management Sept. 30, 2011 357858 $18.44M
First Trust Advisors June 30, 2011 597623 $31.14M
Wells Fargo & Company March 31, 2011 1.11M $44.33M
Norges Bank Investment Management March 31, 2011 676347 $27.19M
Dalton, Greiner, Hartman, Maher & Co March 31, 2011 359823 $14.46M
Perimeter Capital Partners March 31, 2011 337194 $13.56M
Roxbury Capital Management March 31, 2011 328195 $13.19M
Manufacturers Life Insurance Company Dec. 31, 2002 555028 $17.27M